Nano-X Imaging (NNOX) Expected to Announce Quarterly Earnings on Wednesday

Nano-X Imaging (NASDAQ:NNOX) is expected to post its Q2 2026 results before the market opens on Wednesday, September 9th. Analysts expect the company to announce earnings of ($0.1620) per share and revenue of $5.3760 million for the quarter. Interested persons may review the information on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, September 9, 2026 at 8:30 AM ET.

Nano-X Imaging (NASDAQ:NNOX) last posted its quarterly earnings data on Thursday, June 25th. The company reported ($0.16) EPS for the quarter. The firm had revenue of $4.31 million for the quarter. Nano-X Imaging had a negative return on equity of 70.96% and a negative net margin of 716.44%. On average, analysts expect Nano-X Imaging to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Nano-X Imaging Stock Performance

Shares of NNOX stock opened at $0.83 on Monday. Nano-X Imaging has a 12-month low of $0.71 and a 12-month high of $4.71. The business’s fifty day simple moving average is $1.01 and its 200-day simple moving average is $1.71. The company has a market cap of $65.21 million, a PE ratio of -0.53 and a beta of 1.26.

Insider Buying and Selling at Nano-X Imaging

In other news, Director Dan S. Suesskind bought 50,000 shares of the business’s stock in a transaction that occurred on Monday, July 27th. The shares were purchased at an average cost of $0.93 per share, with a total value of $46,500.00. Following the transaction, the director directly owned 50,000 shares in the company, valued at approximately $46,500. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Erez Meltzer bought 36,000 shares of Nano-X Imaging stock in a transaction that occurred on Monday, July 27th. The stock was purchased at an average price of $0.93 per share, with a total value of $33,480.00. Following the purchase, the chief executive officer directly owned 36,000 shares in the company, valued at $33,480. The trade was a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have bought 95,443 shares of company stock valued at $89,706 over the last quarter.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Engineers Gate Manager LP boosted its position in Nano-X Imaging by 272.2% in the fourth quarter. Engineers Gate Manager LP now owns 52,844 shares of the company’s stock valued at $148,000 after buying an additional 38,648 shares during the last quarter. BNP Paribas Financial Markets raised its position in Nano-X Imaging by 64.6% during the 3rd quarter. BNP Paribas Financial Markets now owns 19,743 shares of the company’s stock worth $73,000 after buying an additional 7,749 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in Nano-X Imaging by 529.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 13,794 shares of the company’s stock valued at $71,000 after acquiring an additional 11,604 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in shares of Nano-X Imaging by 20.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,433 shares of the company’s stock valued at $116,000 after acquiring an additional 3,818 shares during the last quarter. Finally, AQR Capital Management LLC purchased a new stake in shares of Nano-X Imaging in the 1st quarter valued at $178,000. 21.49% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently weighed in on NNOX shares. Cantor Fitzgerald restated an “overweight” rating and set a $5.00 target price on shares of Nano-X Imaging in a research note on Monday, August 17th. Zacks Research upgraded Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Weiss Ratings reissued a “sell (e+)” rating on shares of Nano-X Imaging in a report on Wednesday, July 8th. Finally, Alliance Global Partners lowered Nano-X Imaging from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $5.00 to $3.00 in a research note on Tuesday, July 7th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $4.33.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.